MedPharm Strengthens Senior Team with New Appointment
December 16, 2019
MedPharm Ltd strengthens its senior team with the appointment of Lynn Allen as Vice President of Business Development in North America
As part of its continued commitment to serving the North American markets, MedPharm has appointed Lynn Allen as Vice President of Business Development. She will be based in San Francisco, California and will be spearheading MedPharm’s top-line growth throughout North America. MedPharm continues to expand and grow its US CDMO services and remains committed to the pharmaceutical market supporting formulation development, cutting edge performance testing and flexible full-scale manufacture.
Lynn Allen joins MedPharm with a wealth of experience in topical and transdermal contract development and manufacturing. During her career spanning nearly two decades in the CDMO space, Lynn has established her credibility for supporting clients and brings knowledge of the industry to drive forward MedPharm’s expanding service offering. Lynn obtained her MBA from the Booth School of Business at the University of Chicago.
“Lynn is a fantastic addition to the MedPharm team”, commented Eugene Ciolfi, MedPharm’s CEO. “She brings a track record at attracting new customers and establishing strong relationships with key clients. Lynn can provide a local response to MedPharm’s West Coast clients who will increasingly benefit from our expanding facilities in North America”.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm is experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane, and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established Centers of Excellence in the USA and the UK.